Neural transplantation and trophic factors in Parkinson's disease: Special reference to chromaffin cell grafting, NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting

Experimental Neurology

Volumn 137, Issue 2, 1996, Pages 333-344

  Date, Isao ^a   Ohmoto, Takashi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL CULTURE; CELL SURVIVAL; CHROMAFFIN CELL; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NERVE TRANSECTION; NERVE TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PERIPHERAL NERVE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL;

AGE FACTORS; ANIMALS; CELL SURVIVAL; CHROMAFFIN SYSTEM; DOPAMINE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; NERVE GROWTH FACTORS; PARKINSON DISEASE; PERIPHERAL NERVES;

EID: 0029971281     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0034     Document Type: Article

References (61)

1. BACKLUND, E.-O., P.-O. GRANBERG, B. HAMBERGER, E. KNUTSSON, A. MARTENSSON, G. SEDVALL, A. SEIGER, AND L. OLSON. 1985. Transplantation of adrenal medullary tissue to striatum in parkinsonism: First clinical trials. J. Neurosurg. 62: 169-173.
2. BAKAY, R. A. E. 1993. Neurotransplantation: A clinical update. Acta Neurochir. [Suppl] 58: 8-16.
3. BECKER, J. B., AND W. J. FREED. 1988. Adrenal medulla grafts enhance functional activity of the striatal dopamine system following substantia nigra lesions. Brain Res. 462: 401-406.
4. BING, G., M. F. D. NOTTER, J. T. HANSEN, C. KELLOGG, J. H. KORDOWER, AND D. M. GASH. 1990. Cografts of adrenal medulla with C6 glioma cells in rats with 6-OHDA-induced lesions. Neuroscience 34: 687-697.
5. BJORKLUND, A., AND U. STENEVI. 1979. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177: 555-560.
6. BOHN, M. C., L. CUPIT, F. MARCIANO, AND D. M. GASH. 1987. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237: 913-916.
7. CUNNINGHAM, L. A., J. T. HANSEN, M. P. SHORT, AND M. C. BOHN. 1991. The use of genetically altered astrocyte to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum. Brain Res. 561: 192-202.
8. CUNNINGHAM, L. A., M. P. SHORT, X. O. BREAKEFIELD, AND M. C. BOHN. 1994. Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease. Brain Res. 658: 219-231.
9. DATE, I., S. Y. FELTEN, AND D. L. FELTEN. 1989. Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice. Neurosci. Lett. 106: 282-286.
10. DATE, I., S. Y. FELTEN, AND D. L. FELTEN. 1990. Cografts of adrenal medulla with peripheral nerve enhance the survivability of transplanted adrenal chromaffin cells and recovery of the host nigrostriatal dopaminergic system in MPTP-treated young adult mice. Brain Res. 537: 33-39.
11. DATE, I., S. Y. FELTEN, J. A. OLSCHOWKA, AND D. L. FELTEN. 1990. Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice. Exp. Neurol. 107: 197-207.
12. DATE, I., D. L. FELTEN, AND S. Y. FELTEN. 1990. Long-term effect of MPTP in the mouse brain in relation to aging: Neurochemical and immunocytochemical analysis. Brain Res. 519: 266-276.
13. DATE, I., M. F. D. NOTTER, S. Y. FELTEN, AND D. L. FELTEN. 1990. MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain Res. 526: 156-160.
14. DATE, I., S. Y. FELTEN, AND D. L. FELTEN. 1991. The nigrostriatal dopaminergic system in MPTP-treated mice shows more prominent recovery by syngeneic adrenal medullary graft than by allogeneic or xenogeneic graft. Brain Res 545: 191-198.
15. DATE, I., M. F. D. NOTTER, S. Y. FELTEN, AND D. L. FELTEN. 1991. Stereotaxic injection of GD1a ganglioside induces limited recovery of striatal dopaminergic system in MPTP-treated aging mice. J Neurosci. Res. 28: 525-530.
16. DATE, I., Y. YOSHIMOTO, T. IMAOKA, Y. MIYOSHI, Y. GOHDA, T. FURUTA, S. ASARI, AND T. OHMOTO. 1993. Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to aging. Brain Res. 621: 150-154.
17. DATE, I., Y. YOSHIMOTO, Y. MIYOSHI, T. IMAOKA, T. FURUTA, S. ASARI, AND T. OHMOTO. 1993. The influence of donor age on cografting of adrenal medulla with pretransected peripheral nerve. Brain Res. 624: 233-238.
18. DATE, I., Y. YOSHIMOTO, Y. GOHDA, T. FURUTA, S. ASARI, AND T. OHMOTO. 1993. Long-term effects of cografts of pretransected peripheral nerve with adrenal medulla in animal models of Parkinson's disease. Neurosurgery 33: 685-690.
19. DATE, I., Y. MIYOSHI, T. IMAOKA, T. FURUTA, S. ASARI, AND T. OHMOTO. 1994. Efficacy of pretransection of peripheral nerve for promoting the survival of cografted chromaffin cells and recovery of host dopaminergic fibers in animal models of Parkinson's disease. Neurosci. Res. 20: 213-221.
20. DATE, I., Y. YOSHIMOTO, T. IMAOKA, Y. MIYOSHI, T. FURUTA, S. ASARI, AND T. OHMOTO. 1994. Effect of host age upon the degree of nigrostriatal dopaminergic system recovery following cografts of adrenal medulla and pretransected peripheral nerve. Brain Res. 637: 50-56.
21. DATE, I., S. FURUKAWA, AND T. OHMOTO. 1994. Increased nerve growth factor level in the distal stump of transected sciatic nerve in relation to aging and its application for neural grafting. Exp. Neurol. 130: 168-171.
22. DATE, I., S. ASARI, AND T. OHMOTO. 1995. Two-year follow-up study of a parkinsonian patient with severe motor fluctuations treated by cografts of adrenal medulla and peripheral nerve into bilateral caudate nuclei. Neurosurgery 37: 515-519.
23. DUBACH, M. 1991. Adrenal medullary "ribbon" grafts in nonhuman primates: transplant methods. J. Neurosci. Methods 39: 19-28.
24. EMERICH, D. F., S. R. WINN, L. CHRISTENSON, M. A. PALMATIER, F. T. GENTILE, AND P. R. SANBERG. 1992. A novel approach to neural transplantation in Parkinson's disease: Use of polymer-encapsulated cell therapy. Neurosci. Biobehav. Rev. 16: 437-447.
25. FIANDACA, M. S., J. H. KORDOWER, J. T. HANSEN, S.-S. JIAO, AND D. M. GASH. 1988. Adrenal medullary autografts into the basal ganglia of Cebus Monkeys: Injury-induced regeneration. Exp. Neurol. 102: 76-91.
26. FREED, C. R., R. E. BREEZE, N. L. ROSENBERG, S. A. SCHNECK, E. KRIEK, J. QI, T. LONE, Y-B. ZHANG, J. A. SNYDER, T. H. WELLS, L. O. RAMIG, L. THOMPSON, J. C. MAZZIOTTA, S. C. HUANG, S. T. GRAFTON, D. BROOKS, G. SAWLE, G. SCHROTER, AND A. A. ANSARI. 1992. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N. Eng. J. Med. 327: 1549-1555.
27. FURUKAWA, S., I. KAMO, Y. FURUKAWA, S. AKAZAWA, E. SATOYOSHI, K. ITOH, AND K. HAYASHI. 1983. A highly sensitive enzyme immunoassay for mouse β nerve growth factor. J. Neurochem. 40: 734-744.
28. GOLDSMITH, H. S. 1994. Brain and spinal cord revascularization by omental transposition. Neurol. Res. 16: 159-162.
29. GREENE, L. A., AND G. REIN. 1977. Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cells. Brain Res. 129: 247-263.
30. HEIKKILA, R. E., A. HESS, AND R. C. DUVOISIN. 1984. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine in mice. Science 224: 1451-1453.
31. HORELLOU, P., E. VIGNE, M.-N. CASTEL, P. BARNEOUD, P. COLIN, M. PERRICAUDET, P. DELAERE, AND J. MALLET. 1994. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. NeuroReport 6: 49-53.
32. HURTIG, H., J. JOYCE, J. R. SLADEK, AND J. Q. TROJANOWSKI. 1989. Postmortem analysis of adrenal medulla to caudate autograft in a patient with Parkinson's disease. Ann. Neurol. 25: 607-614.
33. IMAOKA, T., I. DATE, Y. MIYOSHI, T. ONO, T. FURUTA, S. ASARI, T. OHMOTO, T. YASUDA, AND M. TSUDA. 1995. Preliminary results of gene transfer to central nervous system by continuous injection of DNA-liposome complex. Cell Transplantation 4 (Suppl. 1): s23-s26.
34. ITAKURA, T., N. KOMAI, Y. RYUJIN, Y. OOIWA, M. NAKAI, AND M. YASUI. 1994. Autologous transplantation of the cervical sympathetic ganglion into the parkinsonian brain: Case report. Neurosurgery 35: 155-158.
35. IWATA, H., T. TAKAGI, K. KOBAYASHI, T. OKA, T. TSUJI, AND F. ITO. 1994. Strategy for developing microbeads applicable to islet xenotransplantation into a spontaneous diabetic NOD mouse. J. Biomed. Mater. Res. 28: 1201-1207.
36. JANKOVIC, J., R. GROSSMAN, C. GOODMAN, F. PIROZZOLO, L. SCHNEIDER, Z. ZHU, P. SCARDINO, A. J. GARBER, S. G. JHINGRAN, AND S. MARTIN. 1989. Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease. Neurology 39: 1227-1234.
37. JAVITCH, J. A., R. J. D'AMATO, S. M. STRITTMATTER, AND S. H. SNYDER. 1985. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82: 2173-2177.
38. KAPLITT, M. G., P. LEONE, R. J. SAMULSKI, X. XIAO, D. W. PFAFF, K. L. O'MALLEY, AND M. J. DURING. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8: 148-154.
39. KORDOWER, J. H., M. S. FIANDACA, M. F. D. NOTTER, J. T. HANSEN, AND D. M. GASH. 1990. NGF-like trophic support from peripheral nerve for grafted rhesus adrenal chromaffin cells. J. Neurosurg 73: 418-428.
40. KORDOWER, J. H., E. COCHRAN, R. D. PENN, AND C. G. GOETZ. 1991. Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann. Neurol. 29: 405-412.
41. LAITINEN, L. V., A. T. BERGENHEIM, AND M. I. HARIZ. 1992. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J. Neurosurg. 76: 53-61.
42. LINDVALL, O. 1989. Transplantation into the human brain: present status and future possibilities. J. Neurol. Neurosurg. Psychiat. Suppl.: 39-54.
43. LOPEZ-LOZANO, J. J., G. BRAVO, J. ABASCAL, B. BRERA, J. SANTOS, AND C. GOMEZ-ANGULO. 1992. Co-transplantation of peripheral nerve and adrenal medulla in Parkinson's disease. Lancet 339: 430.
44. LOPEZ-LOZANO, J. J., B. BRERA, J. ABASCAL, AND G. BRAVO. 1989. Preparation of adrenal medullary tissue for transplantation in Parkinson's disease: A new procedure. J. Neurosurg. 71: 452-454.
45. LOPEZ-LOZANO, J. J., G. BRAVO, AND J. ABASCAL. 1991. Grafting of perfused adrenal medullary tissue into the caudate nucleus of patients with Parkinson's disease. J. Neurosurg. 75: 234-243.
46. MARSDEN, C. D., AND J. A. OBESO. 1994. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 117: 877-897.
47. OLSON, L., E.-O. BACKLUND, T. EBENDAL, R. FREEDMAN, B. HAMBERGER, P. HANSSON, B. HOFFER, U. LINDBLOM, B. MEYERSON, I. STROMBERG, O. SYDOU, AND A. SEIGER 1991. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. Arch. Neurol. 48: 373-381.
48. RAFAEL, H., P. MOROMIZATO, M. ESPINOZA, V. AYULO, AND M. GONZALEZ-PORTILLO. 1991. Transplantation of adrenal medulla and omentum to the putamen by a transinsular pathway for Parkinson's disease. Neurosurgery 28: 481.
49. RICAURTE, G. A., I. IRWIN, L. S. FORNO, D. L. E., E. LANGSTON, AND J. W. LANGSTON. 1987. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Brain Res. 403: 43-51.
50. SAITOH, T., K. NIIJIMA, AND Y. MIZUNO. 1987. Long-term effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine content in young and mature mice. J. Neurol. Sci. 77: 229-235.
51. SCHUELER, S. B., J. D. ORTEGA, J. SAGEN, AND J. H. KORDOWER. 1993. Robust survival of isolated bovine adrenal chromaffin cells following intrastriatal transplantation: a novel hypothesis of adrenal graft viability. J. Neurosci. 13: 4496-4510.
52. SCHUELER, S. B., J. SAGEN, G. D. PAPPAS, AND J. H. KORDOWER. 1995. Long-term viability of isolated bovine adrenal medullary chromaffin cells following intrastriatal transplantation. Cell Transplantation 4: 55-64.
53. SPENCER, D. D., R. J. ROBBINS, F. NAFTOLIN, K. L. MAREK, T. VOLLMER, C. LERANTH, R. H. ROTH, L. H. PRICE, A. GJEDDE, B. S. BUNNEY, K. J. SASS, J. D. ELSWORTH, E. L. KIER, R. MAKUCH, P. B. HOFFER, AND D. E. J. REDMOND. 1992. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N. Eng. J. Med. 327: 1541-1548.
54. STODDARD, S. L., J. E. AHLSKOG, P. J. KELLY, G. M. TYCE, J. A. VAN HEERDEN, A. R. ZINSMEISTER, AND S. W. CARMICHAEL. 1989. Decreased adrenal medullary catecholamines in adrenal transplanted parkinsonian patients compared to nephrectomy patients. Exp. Neurol. 104: 218-222.
55. STROMBERG, I., M. HERRERA-MARSCHITZ, U. UNGERSTEDT, T. EBENDAL, AND L. OLSON. 1985. Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior. Exp. Brain Res. 60: 335-349.
56. TURNER, D. A., AND W. KEARNEY. 1993. Scientific and ethical concerns in neural fetal tissue transplantation. Neurosurgery 33: 1031-1037.
57. UNSICKER, K., S. D. SKAPER, AND S. VARON. 1985. Developmental changes in the responses of rat chromaffin cells to neuronotrophic and neurite-promoting factors. Dev. Biol. 111: 425-433.
58. UNSICKER, K. 1993. The trophic cocktail made by adrenal chromaffin cells. Exp. Neurol. 123: 167-173.
59. WINN, S. R., P. A. TRESCO, B. ZIELINSKI, L. A. GREENE, C. B. JAEGER, AND P. AEBISCHER 1991. Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells. Exp. Neurol. 113: 322-329.
60. ZHOU, J., I. DATE, K. SAKAI, Y. YOSHIMOTO, T. FURUTA, S. ASARI, AND T. OHMOTO. 1993. Xenogeneic dopaminergic grafts reverse behavioral deficits induced by 6-OHDA in rodents: effect of 15-deoxyspergualin treatment. Neurosci. Lett. 163: 81-84.
61. ZHOU, J., I. DATE, K. SAKAI, Y. YOSHIMOTO, T. FURUTA, S. ASARI, AND T. OHMOTO. 1993. Suppression of immunorejection against rat fetal dopaminergic neurons in a mouse brain by 15-deoxyspergualin. Brain Res. 621: 155-160.